U.S., July 30 -- ClinicalTrials.gov registry received information related to the study (NCT07734792) titled 'Tirzepatide in Thrombectomy-Treated Acute Ischemic Stroke: A Randomized Trial' on July 17.
Brief Summary: Acute ischemic stroke caused by blockage of a large artery in the brain is one of the leading causes of death and long-term disability worldwide. For patients with this type of stroke, endovascular thrombectomy (EVT), a procedure that removes the blood clot and restores blood flow to the brain, has become the standard treatment. However, even when blood flow is successfully restored, many patients continue to experience disability because of ongoing brain injury caused by inflammation, oxidative stress, and damage to brain cells...